D. Gupta

Efficacy and Safety of FOLFOX as a Second-Line Chemotherapy for Patients with Locally Advanced and/or Metastatic Carcinoma Gall Bladder – Experience from a Tertiary Care Center in India

A. Sehrawat, K. Parthasarathy, Ketan Dang, 2019, Indian Journal of Medical and Paediatric Oncology.

Colonic Metastases from a Luminal A Type Invasive Ductal Carcinoma Breast: A Rare Case Report

A. Sehrawat, D. Gupta, S. Kotwal, 2020, Indian Journal of Medical and Paediatric Oncology.

Cancer-Associated Venous Thromboembolism in Ambulatory Solid Organ Malignancy Patients: Experience from a Cancer Research Institute

D. Sundriyal, A. Sehrawat, D. Gupta, 2021, Indian Journal of Surgical Oncology.

738P Quality-adjusted time without symptom or toxicity (QA-TWiST) and quality-adjusted progression-free survival (QA-PFS) of first-line (1L) maintenance niraparib in patients with advanced ovarian cancer (OC): Results from the PRIMA trial

D. O’Malley, A. Redondo, D. Lorusso, 2021, Annals of Oncology.

Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment.

A. El-Khoueiry, S. Piha-Paul, P. Judson, 2020 .